Professor Kausik Ray

Recent publications

Emerging Risk Factors Collaboration. Diabetes, fasting glucose and risk of vascular disease Lancet  375(9733):2215-2222.

Ray KK, Seshasai SR, Erqou S, Sever P, Jukema W, Ford I, Sattar N. Statins and all cause mortality reduction in high risk primary prevention a meta-analysis of 11 randomised trials involving 65  299 participants.  Archives of Internal Medicine 2010;170(12), 1024-1031

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, Seshasai SRK, McMurray JJ, Freeman D, Jukema W, Macfarlane  PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis B, Pressel SL, Marchioli R, Maggioni  MRM, Tavazzi L, Tognoni G, Kjekshus J, Pedersen T, Cook T, Gotto AM, Nakamura H, Ray KK, Ford I. Statins and the risk of incident diabetes: a collaborative meta-analysis of thirteen randomised statin trials involving 91,141participants. Lancet 2010, 375,(9716), 735-42

Emerging Risk Factors Collaboration. C reactive protein concentration and the risk of CHD, stroke and non-vascular mortality. Individual data analysis of 126 338 participants from 48 studies Lancet 2010, 375, 132-40

Emerging Risk Factors Collaboration. Interplay of Triglycerides, HDL-C  and non-HDL-C concentrations on risk of CHD and stroke. Individual  data analysis of 291 107 participants from 66 cohorts.  JAMA 2009, 302, 1993-2000

Emerging Risk Factors Collaboration. Lipoprotein (a) concentration.and the risk of CHD, stroke and non- vascular mortality. Individual data analysis of 121 944 participants from 34 cohorts. JAMA 2009,  302, 412-423

Ray KK, Sheshai SR, Wijesureya S, Simvakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. More intensive control of glucose and cardiovascular outcomes: a meta-analysis of clinical trials.  Lancet  2009, 373, 1765-72

Ray KK, Morrow DA, Cannon CP, Sabatine CP, Shui A, Rifai N, Braunwald E. Neopterin a novel marker of monocyte activation and long-term prognosis after ACS. Circulation 2007; 115 (24), 3071-8

Ray KK, Cannon CP, Cairns R, Tonkin AJ, Sacks F, Jackson G, McCabe C, Braunwald E. The early and late benefits of high dose atorvastatin in patients with acute coronary syndromes. Results from the  PROVE IT-TIMI 22 trial. JACC 2005; 46 (8), 1405-1410